Search for company
Explore more than 1.3 million company profiles from emerging markets

Kahira Pharmaceuticals & Chemical Industries Co. S.A.E (القاهرة للأدوية والصناعات الكيماوية) (Egypt)

Main Activities: Pharmaceutical and Medicine Manufacturing
Quote Chart
Quote Summary
Last Price 20.05
Volume 390
Turnover 7,839
Index Healthcare and Pharmaceuticals
Market Egyptian Stock Exchange
Ticker CPCI.CA
Market Cap Market Cap 239,537
52 Week High 27.97
52 Week Low 20.00
P/E 5.83
EPS 3.44
Dividend Yield 1.26 (June 30, 2014)
Bookvalue 493,306
Enterprise Value 193,178
Quote updated on March 29, 2015
Note: data in EGP Thousands.
Select Items to chart them. 2014 Y
Net sales revenue
Total Operating Revenue
Operating profit (EBIT)
Net Profit(Loss)
Total Assets 493,306
Total equity
Operating Profit Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to equity
Quick ratio
Cash Ratio
Note: units in Thousands. Statement: Audited, Consolidated
Source: World's Vest Base, EMIS Company Database.
Company Description

Cairo Pharmaceuticals was established in 1962 through the merger of three laboratories. Cairo Pharmaceuticals and Chemical Industries (CPCI) is mainly engaged in the manufacture and trade of pharmaceutical products and it is specialized in human and veterinary products in the forms of soft gelatin capsules, tablets, syrups, suspensions, ampoules, eye and nasal drops, and suppositories, such as analgesics antipyretics antirheumatics, single vitamins, antibiotics, urologics, ophthalmics and cardiacs…

Main Products

Human and veterinary drugs, Suppositories, Cosmetics, Chemical products.

Contact Information

Legal Address
4 Abd El-Hamed El-Deeb St.,Victoria Sguare, Shoubra,P.O Box 793
Cairo; Greater Cairo; Map
Tel: +20-22028596,+20-22021431
Fax: +20-22025477

Full name: Kahira Pharmaceuticals & Chemical Industries Co. S.A.E

Status: Listed
Legal Form: Joint Stock Company
Operational Status: Operational
ISIN CODE : EGS38391C016
Incorporation Date: 1991

Basic Information
Total Employees:
Outstanding Shares:
: ()
Registered Capital:
Financial Auditors:
Key Executives
Ownership Details
Pharmaceuticals Holding Company
Corporate Actions
EMIS Benchmark Score
EMIS DealWatch Deals
DealMonitor Deal Intents
EMIS DealWatch News
Financial Documents/Annual Reports
Competitors - Egypt

Receive our Global EMIS Insider

The Global EMIS Insider is a our monthly source of Emerging Markets Information Service (EMIS) functionality enhancements and new content releases in each of our countries worldwide.
First Name: *
Country: *
Last Name: * Company: *
Email: * Position: *
Security Code: *   * Indicates required field.

EMIS is part of the Euromoney Institutional Investor PLC group of companies. Click here for more details on our group's activities.
We will use the information you provide here to process your order/registration/request including communicating with you about it. If you are registering for a trial, you will receive a follow up email and/or call asking you about your trial. As part of the trial, you may also receive email updates and other features as specified for that product. We may monitor your use of our website(s). As an international group, we may transfer your data on a global basis. Subject to your choices below, we may also use your data for marketing purposes. By submitting your details, you will be indicating your consent to the use of your data as identified here. Further information is set out in our privacy policy on this site.

Please tick if you don't want to receive details of products, services and special offers from our group companies by:

Phone    Fax    Email    Mail

Please tick if you don't want to receive details of relevant products, services and special offers from selected companies outside our group

I have read and agree to the Terms and Conditions.

I have read and agree to the Privacy Policy.